Received Feb 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPAB | HEP A + HEP B (TWINRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
child of 5 years of age was given Twinrix adult formulation; Adult product administered to child; This non-serious case was reported by a nurse via call center representative and described the occurrence of overdose in a 5-year-old male patient who received HAB (Twinrix) for prophylaxis. On an unknown date, the patient received Twinrix. On an unknown date, an unknown time after receiving Twinrix, the patient experienced overdose (Verbatim: child of 5 years of age was given Twinrix adult formulation) and adult product administered to child (Verbatim: Adult product administered to child). The outcome of the overdose and adult product administered to child were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 04-FEB-2025 The healthcare professional reported a child of 5 years of age was given Twinrix adult formulation which led to overdose and adult product administered to child.